India IPO Market Update, Overview, Investment Rationale: ICICI Securities
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Securities Report
Issues where Securities and Exchange Board of India observations have been received and still valid-
Emcure Pharmaceuticals - One of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
VLCC Health Care - VLCC’s stature as a leading brand in the Indian wellness and beauty Industry - over 30 years of operations, the VLCC brand is well known to and enjoys a high level of trust by customers.
Adani Wilmar - Differentiated and diversified product portfolio with market leading brands to capture large share of kitchen spends across India.
Issues where offer documents are filed and awaiting SEBI observations-
Aether Industries - Aether Industries Ltd. is one of the fastest growing specialty chemical companies in India, growing at a compound annual growth rate of nearly 49.5% between fiscal 2019 and fiscal 2021.
Vedant Fashions (Manyavar) - It is the market leader in the Indian celebration wear market with a diverse portfolio of brands catering to the aspirations of the entire family. Differentiated business model combining the strengths of retailing with branded consumer play.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.